News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Clinical trials news

Show

From To
Clinical trials
The Rise of Unregulated Drug Trials in South America

Human testing is a global game dominated by corporations, called contract research organizations (CROs), that help Big Pharma bring new molecules from the lab to your medicine cabinet.

Published
28 September 2011
From
The Nation
Clinical trials
South Africa: Medicines Control Council Delays HIV Drug Trials

The Democratic Alliance believes it is unacceptable for the Medicines Control Council (MCC) to adopt an obstructionist attitude in approving the field trials of locally developed drugs that could play a significant role in our battle against HIV/AIDS.

Published
14 September 2011
From
AllAfrica
Clinical trials
U.S. scientists knew 1940s Guatemalan STD studies were unethical, panel finds

U.S. government researchers who purposely infected unwitting subjects with sexually transmitted diseases in Guatemala in the 1940s had obtained consent a few years earlier before conducting similar experiments in Indiana, investigators reported Monday.

Published
30 August 2011
From
Washington Post
Cancer
Cancer research in 'golden era', says charity chief

The head of the UK's leading cancer charity has said understanding of the disease is advancing "exponentially", as potentially groundbreaking trials to genetically test tumours of 9,000 newly diagnosed patients begin.

Published
23 August 2011
From
Guardian
New and experimental hepatitis C treatment
Treatment Action Group publishes Guide to Clinical Trials for People With Hepatitis C

There are many new hepatitis C drugs being studied in clinical trials. People with hepatitis C have many options to choose from. Whether you have hepatitis C or another medical condition, deciding to participate in a clinical trial can be complicated. Having more information can help you decide whether or not to participate in a clinical trial, and which trial, or trials, may be right for you.

Published
17 August 2011
From
Treatment Action Group
Transmission and prevention
The research agenda for antiretroviral prevention – now it gets complex

We now know that starting antiretroviral therapy early, pre-exposure prophylaxis (PrEP) and vaginal microbicides can all have an impact on HIV transmission, Victor de Gruttola told a satellite

Published
18 July 2011
By
Roger Pebody
New and experimental HIV treatments
Tobira Therapeutics Inc. Initiates Phase IIb Trial of Cenicriviroc, a Novel CCR5/CCR2 Antagonist for the Treatment of HIV Infection

Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).

Published
22 June 2011
From
Tobira
New and experimental hepatitis C treatment
Activists Call for Earlier Access to Hep C Treatments

Hepatitis and HIV activists have called for pharmaceutical companies and drug regulators to provide earlier access to new hepatitis C virus (HCV) therapies in development to people at greater need of treatment, including people on transplant wait lists and those coinfected with HCV and HIV.

Published
17 June 2011
From
AIDSMeds
Clinical trials
Now, the confidentiality of people taking part in clinical trials in Russia is protected

Thanks to the active position of patient organizations and associations of people living with HIV, specific amendments ensuring protection of the personal data of patients taking part in clinical trials have been introduced into the Russian laws.

Published
07 June 2011
From
EATG
Pharmaceutical industry
Hepatitis C: Greenwich doctor accused of insider trading

An Ivy League-trained physician who became a health care investment analyst surrendered Wednesday on charges that accuse him of evading $30 million in losses for a hedge fund by obtaining confidential information from a French doctor about clinical liver disease drug trials.

Published
14 April 2011
From
HCV New Drugs Research
← Prev1...23456...8Next →

Filter by country